Tibet Duo Rui Pharmaceutical (301075.SZ): Sodium Bicarbonate Injection Pharmaceutical Registration Accepted

Tibet Duo Rui Pharmaceutical (301075.SZ) announced that its wholly-owned subsidiary, Hubei Duo Rui Pharmaceutical Co., Ltd. (referred to as "Hubei Duo Rui"), has received a notification of acceptance of registration for sodium bicarbonate injection issued by the National Medical Products Administration. The National Medical Products Administration has reviewed the drug registration application for the above-mentioned drug and has decided to accept it. Sodium bicarbonate injection is mainly used for metabolic acidosis, urine alkalization, and intravenous infusion for the treatment of certain drug poisoning.